{"id":210270,"name":"ORPHAZYME US, INC.","slug":"orphazyme-us-inc","state":"IL","country":"United States of America","description":"Development of Heat-Shock Protein response for treatment of neurodegenerative rare disease","totalSpending":45000,"filings":5,"yearlySpending":[{"year":2020,"income":0},{"year":2021,"income":45000}],"issues":["HCR","PHA","MED"],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["PATROSKI LAWSON","BENJAMIN MASON","KATHERINE LANDES"],"govEntities":["SENATE"],"sampleDescriptions":["H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act","H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act","H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act\nH.R. 482/S. 350, Newborn Screening Reauthorization Act"],"years":[2020,2021]}